The bill’s absence from the proposed amendments to the US National Defence Authorisation Act comes as a reprieve for the two biotech firms.
Home » WuXi AppTec, WuXi Biologics surge on slimmer chances of US Biosecure Acts passage
The bill’s absence from the proposed amendments to the US National Defence Authorisation Act comes as a reprieve for the two biotech firms.